# Sonoma Pharmaceuticals Posts $7.17 Million in Fiscal Q2 Revenue

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54428
Published: 2026-11-11T20:33:08.000Z
Updated: 2026-11-11T20:33:08.000Z
Section: Business

> The company recorded a basic and diluted GAAP net loss per share of $0.01 for the quarter ended Sept. 30, 2026.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) recorded $7.174 million in revenue and a GAAP net loss per share of $0.01 on both a basic and diluted basis for its second fiscal quarter of 2027, which ended Sept. 30, 2026.

The company announced the results on Nov. 10, 2026.